272 reports of this reaction
1.3% of all REMDESIVIR reports
#19 most reported adverse reaction
SEPTIC SHOCK is the #19 most commonly reported adverse reaction for REMDESIVIR, manufactured by Gilead Sciences, Inc.. There are 272 FDA adverse event reports linking REMDESIVIR to SEPTIC SHOCK. This represents approximately 1.3% of all 20,319 adverse event reports for this drug.
Patients taking REMDESIVIR who experience septic shock should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SEPTIC SHOCK is a less commonly reported adverse event for REMDESIVIR, but still significant enough to appear in the safety profile.
In addition to septic shock, the following adverse reactions have been reported for REMDESIVIR:
The following drugs have also been linked to septic shock in FDA adverse event reports:
SEPTIC SHOCK has been reported as an adverse event in 272 FDA reports for REMDESIVIR. This does not prove causation, but indicates an association observed in post-market surveillance data.
SEPTIC SHOCK accounts for approximately 1.3% of all adverse event reports for REMDESIVIR, making it a notable side effect.
If you experience septic shock while taking REMDESIVIR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.